the methodology known as chemiluminescence detection-high performance liquid chromatography (CL-HPLC), which is both sensitive and selective enough to measure lipid-class hydroperoxide levels in foods, as well as in biological samples such as blood plasma and tissues (1-9). A unique post-column chemiluminescence reagent consisting of cytochrome c and luminol in an alkaline borate-buffered solution is commonly utilized for CL-HPLC. Using CL-HPLC, formation of mono-, bis-, and tris-hydroperoxides was found to occur during the initial stage of triacylglycerol oxidation in food oils (6, 7) . Animal studies have shown that long-term fish oil consumption results in a high risk of membrane phospholipid peroxidation (i.e., abnormal accumulation of phosphatidylcholine hydroperoxide, PCOOH, together with an increased need for a-tocopherol as a membrane antioxidant (9). Moreover, membrane phospholipid peroxidation (PCOOH accumulation) increases with aging (senescence) (2). These findings strongly suggest the importance of determining lipid peroxidation levels in food and biological systems (refer to comprehensive reviews (10) for background information relating to lipid peroxidation).
Importance of Evaluation of Lipid Peroxidation in Food and Biological Samples
In 1987, Miyazawa et al. established the methodology known as chemiluminescence detection-high performance liquid chromatography (CL-HPLC), which is both sensitive and selective enough to measure lipid-class hydroperoxide levels in foods, as well as in biological samples such as blood plasma and tissues (1-9). A unique post-column chemiluminescence reagent consisting of cytochrome c and luminol in an alkaline borate-buffered solution is commonly utilized for CL-HPLC. Using CL-HPLC, formation of mono-, bis-, and tris-hydroperoxides was found to occur during the initial stage of triacylglycerol oxidation in food oils (6, 7) . Animal studies have shown that long-term fish oil consumption results in a high risk of membrane phospholipid peroxidation (i.e., abnormal accumulation of phosphatidylcholine hydroperoxide, PCOOH, together with an increased need for a-tocopherol as a membrane antioxidant (9) . Moreover, membrane phospholipid peroxidation (PCOOH accumulation) increases with aging (senescence) (2). These findings strongly suggest the importance of determining lipid peroxidation levels in food and biological systems (refer to comprehensive reviews (10) for background information relating to lipid peroxidation).
Pure Hydroperoxide Standards for Quantification
One of the challenges faced by many researchers in measuring lipid hydroperoxides using CL-HPLC or other HPLC techniques is finding suitably pure hydroperoxide standards (11, 12) . Lipid hydroperoxides prepared from photo-or free radical-oxidized lipids are generally used as standard compounds. However, the purity of the hydroperoxides in such standards is not necessarily high (12) . Impurities in the standards can be attributed to a number of analytical errors.
Over 50 y ago it was reported that under acidic conditions, some vinyl ethers can react with organic hydroperoxides to form perketals (13, 14) . Thus, we predicted that this reaction could be applied for the preparation of pure lipid hydroperoxides, which was achieved using a vinyl-ether molecule (2-methoxypropene, MxP) (15) . The procedures require protecting the hydroperoxide group as a perketal using MxP. The perketal is then separated using HPLC, and the pure hydroperoxide is regenerated from the perketal.
The above-mentioned reactions are useful for the preparation of lipid hydroperoxides (e.g., PCOOH), although the reactions sometimes yield unknown brown byproducts. Hence, we recently reported a method to improve the reaction conditions, and demonstrated the synthesis of pure PCOOH without byproduct formation (16) . In particular, the PCOOH isomer 1-palmitoyl-2-(9-hydroperoxyoctadecadienoyl)-sn-glycero-3-phosphocholine (16:0/9-HpODE PC) was synthetically prepared ( Fig. 1) as follows: linoleic acid was oxidized for 48 h at 40˚C. Among the resulting oxidation products, 9-hydroper-oxyoctadecadienoic acid (9-HpODE) was chromatographically fractionated, and its hydroperoxide group was protected by MxP. The protected fatty acid was subsequently purified to yield 9-HpODE, in which the hydroperoxide group was protected by MxP. The protected fatty acid hydroperoxide was then purified and esterified with lysoPC (16:0) in chloroform containing N,N′-dicyclohexylcarbodiimide and dimethylaminopyridine under N2 atmosphere for 24 h (16, 17) . The synthesized diacylphosphocholine was finally deprotected, and the resultant 16:0/9-HpODE PC was chromatographically purified. In addition, another PCOOH isomer, namely 1-palmitoyl-2-(13hydroperoxyoctadecadienoyl)-sn-glycero-3-phosphocholine (16:0/13-HpODE PC) was prepared from PC (16:0/18:2 PC) using soybean 15-lipoxygenase and MxP (15) (16) (17) . Thus, we are currently using these PCOOH standards (16:0/9-HpODE PC and 16:0/13-HpODE PC), along with CL-HPLC, as well as a newly developed HPLC-tandem mass spectrometry (MS/MS) system, for quantification of lipid hydroperoxides (PCOOH) in clinical samples (17) as described below. The pure PCOOH was also used for cell culture studies to evaluate PCOOH pathogenicity.
A Newly Developed HPLC-MS/MS System for PCOOH Quantification
In recent years, plasma PCOOH concentrations have been measured at the molecular species level using LC-MS/MS. Hui et al. reported that concentrations of PCOOH, specifically 1-palmitoyl-2-hydroperoxyoctadecadienoyl-sn-glycero-3-phosphocholine (16:0/HpODE PC) and 1-stearoyl-2-hydroperoxyoctadecadienoyl-sn-glycero-3-phosphocholine (18:0/ HpODE PC), in plasma samples were 89 and 32 pmol/mL, respectively (18) , although the authors did not mention the position of the hydroperoxide group in the fatty acid. As the determination of the hydroperoxide position can be helpful in the elucidation of the in vivo lipid peroxidation mechanisms (i.e. radical-, enzyme-, and/or singlet oxygen-oxidation) (10), analysis of these PCOOH isomers is necessary for the investigation of oxidative stress-related pathophysiology. Recently, we investigated various (HPLC-)MS/MS conditions to quantify major 16:0/HpODE PC isomers, such as 16:0/9-HpODE PC and 16:0/13-HpODE PC, in plasma from healthy subjects and patients with angiographically significant stenosis (17) .
MS/MS analysis was carried out using the prepared PCOOH isomer Summary Increasing evidence for phosphatidylcholine hydroperoxide (PCOOH) as a marker of oxidative food deterioration and oxidative diseases has revealed the need for a pure PCOOH standard and a reliable quantification method. Recently, we synthesized the PCOOH isomers 1-palmitoyl-2-(9-hydroperoxyoctadecadienoyl)-sn-glycero-3-phosphocholine, (16:0/9-HpODE PC) and 1-palmitoyl-2-(13-hydroperoxyoctadecadienoyl)-sn-glycero-3-phosphocholine (16:0/13-HpODE PC). Using these standards along with liquid chromatography-tandem mass spectrometry, a reliable quantification method was developed. This mini-review describes these analytical techniques, with a particular emphasis on clinical sample analysis. Key Words phosphatidylcholine hydroperoxide, lipid peroxidation, food deterioration, oxidative diseases, mass spectrometry CID of 16:0/9-HpODE PC produced a product ion (m/z 388) through the neutral loss of 169 Da and 255 Da (corresponding to the palmitic acid) ( Fig. 2B) , whereas a product ion (m/z 541) was generated from 16:0/13-HpODE PC through the neutral loss of 88 Da and phosphatidylcholine (Fig. 2B ). Sodiated cyclophosphane (m/z 147) was observed in both spectra (19) . These findings provide support for the possibility that a novel MRM assay for PCOOH isomer analysis could be developed based on the fragmentation of [M1Na] 1 . To evaluate this possibility, LC-MS/MS MRM analysis was performed. We analyzed the reference PCOOH isomer (16:0/9-HpODE PC or 16:0/13-HpODE PC) with various MRM programs (e.g., 790/184, 812/541, 812/388, and 812/147) and detected peaks corresponding to PCOOH (Figs. 2C, D) . However, these peak intensities, particularly 790/184, were easily affected by instrumental conditions, especially metal ions (Na 1 ) in the flow path or ion source, which suggests that [M1Na] 1 (m/z 812) would be more useful than [M1H] 1 (m/z 790) in developing reproducible MRM profiles. Thus, we added extra Na 1 (i.e., 0.1 mM sodium acetate) to the mobile phase and achieved stable and quantitative detection of sodiated PCOOH by MRM (812/541, 812/388, and 812/147) (Figs. 2E, F). Generally, nonvolatile salts containing sodium put a burden on MS instrumentation (20) . We were able to reduce the amount of Na 1 to 0.1 mM in the mobile phase because PCOOH and other matrix compounds were separated as much as possible. The MRM programs 812/388 and 812/541 could detect PCOOH only if there was a hydroperoxide group at the 9-and 13-position, respectively, of the fatty acid (linoleic acid) in the PCOOH molecule. MRM 812/147 enabled PCOOH detection, regardless of the position of the hydroperoxide group in the fatty acid.
Determination of Phosphatidylcholine Hydroperoxide (PCOOH) as a Marker of Membrane Lipid Peroxidation
Under optimized quantification procedures (e.g., detection and extraction conditions (17)), we measured the concentration of PCOOH isomers in plasma samples of healthy subjects. The plasma PCOOH concentrations in healthy subjects (reported as means6SDs, n58) were determined to be 33.1610.2 pmol/mL for 16:0/9-HpODE PC (MRM 812/388) and 36.1611.5 pmol/mL for 16:0/13-HpODE PC (MRM 812/541), while a higher concentration (72.3623.5 pmol/ mL) was found for MRM 812/147. These findings support our rationale that MRM (812/388 and 812/541) could detect PCOOH only if there was a hydroperoxide group at the 9-and 13-position, respectively, of the fatty acid (linoleic acid) in the PCOOH molecule, whereas MRM 812/147 enabled PCOOH detection, regardless of the position of the hydroperoxide group in the fatty acid. The sum of the concentrations of 16:0/9-HpODE PC and 16:0/13-HpODE PC (69.3623.5 pmol/mL) was found to be very close to that obtained for MRM 812/147 (72.3623.5 pmol/mL), suggesting that other isomers (16:0/10-and 12-HpODE PC) scarcely exist in human plasma.
Finally, we measured the concentrations of PCOOH in patients with angiographically significant stenosis. The respective PCOOH concentrations were determined to be 45.2618.1 (812/388), 52.4624. 6 (812/541), and 97.3639.5 (812/ 147) pmol/mL (reported as means6SDs, n512). These concentrations tended to be higher than those of healthy subjects (p50.06~0.13), implying the involvement of phospholipid peroxidation in the development of atherosclerosis. This possibility needs further investigation (agematched control study) in future trials, mainly because the patients that participated in this study are aged 69611 y, and age is thought to correlate with increased phospholipid peroxidation (2). While these data are still preliminary, it seems that there are differences in the ratio of plasma 16:0/9-HpODE PC and 16:0/13-HpODE PC among individuals, and this may be due to progression of different oxidation processes (i.e. radical-, non-radical-, and enzymatic-oxidation). Thus, the developed LC-MS/MS MRM system is useful for studying biological samples, including human plasma, and may be helpful in elucidating the incompletely understood pathophysiology of oxidative stress-related diseases, such as atherosclerosis.
Biological Roles of PCOOH in Atherogenesis
As mentioned above, phospholipid peroxidation plays an important role in the pathogenesis of diseases, such as atherosclerosis (2-5). However, the biological mechanism has not been definitively established. We previously found that THP-1 cell adhesion to intracellular adhesion molecule-1 was increased in the presence of PCOOH (21, 22) . The result indicates that PCOOH in Ox-LDL may be involved in monocyte adherence to the arterial wall during the initiation of atherosclerosis. In another experiment, we found that PCOOH stimulated angiogenic responses in HUVECs (23) . These previous findings (21-23) together with our recent results (24) will enhance our fundamental understanding of the involvement of PCOOH in Ox-LDL in the development of atherosclerosis, although further studies are needed to investigate atherogenic processes (e.g., cytotoxicity, apoptosis, mitotic catastrophe, ferroptosis, and angiogenesis) of PCOOH in Ox-LDL.
Conclusion
Increasing evidence for phosphatidylcholine hydroperoxide (PCOOH) as a marker of oxidative food deterioration and oxidative diseases has revealed the need for a reliable PCOOH quantification method. In this review, we introduced current analytical techniques for the analysis of PCOOH (reference preparation and detection capability), focusing on PCOOH isomers. A series of experimental data from PCOOH isomer analysis may elucidate the peroxidation mechanisms of lipid biomembranes (i.e. radical-, non-radical-, and enzymaticoxidation). Furthermore, experimental data reported in this review suggest that PCOOH has potent atherogenic and angiogenic functions. Further elucidation of the involvement of lipid peroxidation in oxidative stress-related diseases such as atherosclerosis is expected in the future. 
